fruquintinib
hutchmed
['fruquintinib', 'rectal', 'fresco-2', 'colorectal']
#esmo22 highlights fresco-2: a global phase 3 multiregional clinical trial (mrct) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic #colorectalcancer with 
The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.